Product Images Pregablin

This text appears to contain information about a mathematical formula involving weight and serum creatinine levels for patients. It suggests calculating a value by multiplying weight with a coefficient and serum creatinine levels, with a specific adjustment factor for female patients. This formula may be relevant in medical or laboratory settings for assessing kidney function or other health parameters.*

This text provides information about Pregabalin Capsules CV, manufactured by Macleods Pharma USA. It includes details about the dosage, storage instructions, and dispensing guidelines. The medication guide is meant to be given to each patient by the pharmacist. The capsules contain 25 mg of Pregabalin USP. The manufacturing location is in Baddi, Himachal Pradesh, INDIA. The text also mentions standard dosage instructions and storage conditions.*

This is a product label for Pregabalin Capsules with a dosage of 150 mg. The medication guide should be dispensed to each patient, and only a total of 90 capsules should be dispensed. The usual dosage information can be found in the accompanying prescribing information. The capsules should be stored in a tightly closed container at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The product is manufactured by Macleods Pharmaceuticals Ltd in Baddi, Himachal Pradesh, India for Macleods Pharma USA, Inc.*

This text provides information about Pregabalin capsules CV with a strength of 200 mg. It includes details on dispensing the medication guide to patients, the recommended dosage, storage instructions, and manufacturing information. The medication is dispensed in a tightly closed container and should be stored at 20° to 25°C. The manufacturing details include companies in the USA and India.*

This information is about Pregabalin capsules with a dosage of 225 mg. It includes instructions for pharmacists to dispense along with a medication guide to patients. The capsules should be stored in a closed container at 20° to 25°C and out of reach of children. Further details can be found in the accompanying prescribing information.*

This is a description of Pregabalin Capsules CV containing 300 mg of Pregabalin. The medication guide should be dispensed to each patient. The usual dosage and prescribing information should be followed. The capsules should be dispensed in a tightly closed container and stored at 20° to 25°C. The product is manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd in India. Keep out of reach of children.*

This text is a label for Pregabalin capsules with information on dosage, storage instructions, and manufacturer details. It specifies the usual dosage, storage conditions, and advises the pharmacist on dispensing. The capsules are produced by Macleods Pharma USA, Inc. for Macleods Pharmaceuticals Ltd. The quantity is mentioned as only 90 capsules.*

This text contains information about Pregabalin capsules with NDC code 33342-167-10. It includes dosage instructions and storage details. The medication guide should be dispensed to each patient by the pharmacist. The capsules should be stored in a tightly closed container at 20° to 25°C (68° to 77°F) and kept out of the reach of children. The manufacturing details are also provided.*

Not available.*

This data presents the percentage of patients who experienced improvement in pain based on different doses of Pregabalin and Placebo. It includes the Pregabalin doses of 600mg, 450mg, and 300mg per day, along with the Placebo. The graph depicts the varying levels of pain improvement from baseline, with percentages ranging from 0 to 100.*

This text provides information on the improvement of patients taking Pregabalin 100 mg three times a day and Progabalin 80 mg three times a day. It also mentions the percentage of improvement in pain from baseline.*

This text appears to be related to medication dosage instructions. It mentions "Seizwe Reduction" and shows various dose amounts labeled as "P00t," "Ap

This is a data table showing responder rates for different doses of a medication compared to a placebo. The responder rates are given as percentages for doses of 2.5 mg/kg/day and 10 mg/kg/day. The responders rates for these doses are as follows: 22.6%, 29.1%, and 40.6%. The placebo responder rate is not specified in the provided text.*